You Don’t Have to Hide During a Joint Commission Survey: The Role of Leadership (EP Video)

Platelet inhibitors, especially the glycoprotein (GP) IIb/IIIa receptor antagonists, have demonstrated their effectiveness in reducing the acute ischemic complications of percutaneous coronary intervention (PCI) and in improving clinical outcomes in patients with acute coronary crisis.

This study was designed to determine if ketoconazole or indomethacin could reduce the adverse effects of extracorporeal circulation.